GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Family Office of America Inc (OTCPK:FOFA) » Definitions » Price-to-Free-Cash-Flow

FOFA (Family Office of America) Price-to-Free-Cash-Flow : N/A (As of May. 11, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Family Office of America Price-to-Free-Cash-Flow?

As of today (2025-05-11), Family Office of America's share price is $0.32187. Family Office of America's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.01. Hence, Family Office of America's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Family Office of America's Price-to-Free-Cash-Flow or its related term are showing as below:

FOFA's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 28.33
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Family Office of America's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 67.40% per year.

During the past 10 years, Family Office of America's highest 3-Year average Free Cash Flow per Share Growth Rate was 96.10% per year. The lowest was 67.40% per year. And the median was 81.75% per year.


Family Office of America Price-to-Free-Cash-Flow Historical Data

The historical data trend for Family Office of America's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Family Office of America Price-to-Free-Cash-Flow Chart

Family Office of America Annual Data
Trend Jul06 Jul07 Jul08 Jul09 Jul10 Dec11 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Family Office of America Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Family Office of America's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Family Office of America's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Family Office of America's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Family Office of America's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Family Office of America's Price-to-Free-Cash-Flow falls into.


;
;

Family Office of America Price-to-Free-Cash-Flow Calculation

Family Office of America's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.32187/-0.005
=N/A

Family Office of America's Share Price of today is $0.32187.
Family Office of America's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Family Office of America  (OTCPK:FOFA) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Family Office of America Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Family Office of America's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Family Office of America Business Description

Traded in Other Exchanges
N/A
Address
6898 S. University Boulevard, Suite 100, Centennial, CO, USA, 80122
Family Office of America Inc is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality-agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
Executives
Bin Wang director 112 RICO DR. NORTH, MORGANVILLE NJ 07751